400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Anti-infection / Antiparasitic / Tafenoquine/他非诺喹
CAS No.: 106635-80-7
Synonyms: WR 238605;SB-252263-AAB;Krintafel
Tafenoquine is an oral active antimalaria drug that is being investigated as a potential treatment for malaria, as well as for malaria prevention.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT01376167 | Malaria, Vivax | Phase 2 | Completed | - | Bangladesh ... more >> GSK Investigational Site Bandarban, Bangladesh Brazil GSK Investigational Site Manaus, Amazonas, Brazil, 69040-000 GSK Investigational Site Porto Velho, Rondônia, Brazil, 76812-329 Cambodia GSK Investigational Site Oddar Meancheay Province, Cambodia Ethiopia GSK Investigational Site Gondar, Ethiopia GSK Investigational Site Jimma, Ethiopia India GSK Investigational Site Bikaner, India GSK Investigational Site Chennai, India, 600016 GSK Investigational Site Lucknow, India, 226003 GSK Investigational Site Secunderabad, India, 500 003 Peru GSK Investigational Site Iquitos, Loreto, Peru, Iqui 01 Philippines GSK Investigational Site Rio Tuba, Bataraza, Philippines, 5306 Thailand GSK Investigational Site Bangkok, Thailand, 10400 GSK Investigational Site Tak, Thailand, 63110 Collapse << |
NCT02184637 | Malaria, Vivax | Phase 1 | Completed | - | United States, Maryland ... more >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Collapse << |
NCT01376167 | - | - | Completed | - | - |
实验方案
技术信息
CAS号 | 106635-80-7 | 储存条件 |
|
|
分子式 | C24H28F3N3O3 | 运输 | 蓝冰 | |
分子量 | 463.49 | 别名 | WR 238605;SB-252263-AAB;Krintafel;他非诺喹 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT01376167 | Malaria, Vivax | Phase 2 | Completed | - | Bangladesh ... more >> GSK Investigational Site Bandarban, Bangladesh Brazil GSK Investigational Site Manaus, Amazonas, Brazil, 69040-000 GSK Investigational Site Porto Velho, Rondônia, Brazil, 76812-329 Cambodia GSK Investigational Site Oddar Meancheay Province, Cambodia Ethiopia GSK Investigational Site Gondar, Ethiopia GSK Investigational Site Jimma, Ethiopia India GSK Investigational Site Bikaner, India GSK Investigational Site Chennai, India, 600016 GSK Investigational Site Lucknow, India, 226003 GSK Investigational Site Secunderabad, India, 500 003 Peru GSK Investigational Site Iquitos, Loreto, Peru, Iqui 01 Philippines GSK Investigational Site Rio Tuba, Bataraza, Philippines, 5306 Thailand GSK Investigational Site Bangkok, Thailand, 10400 GSK Investigational Site Tak, Thailand, 63110 Collapse << |
NCT02184637 | Malaria, Vivax | Phase 1 | Completed | - | United States, Maryland ... more >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Collapse << |
NCT01376167 | - | - | Completed | - | - |
NCT02802501 | Malaria, Vivax | Phase 3 | Recruiting | November 29, 2019 | Indonesia ... more >> GSK Investigational Site Recruiting Jakarta, Indonesia, 10430 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Collapse << |
NCT01205178 | Malaria | Phase 1 | Completed | - | Thailand ... more >> GSK Investigational Site Bangkok, Thailand, 10700 GSK Investigational Site Tak, Thailand, 63110 Collapse << |
NCT02216123 | Malaria, Vivax | Phase 3 | Completed | - | Brazil ... more >> GSK Investigational Site Manaus, Amazonas, Brazil, 69040-000 Colombia GSK Investigational Site Cali, Colombia GSK Investigational Site Monteria, Colombia Ethiopia GSK Investigational Site Gondar, Ethiopia GSK Investigational Site Jimma, Ethiopia Peru GSK Investigational Site Iquitos, Loreto, Peru, Iqui 01 Thailand GSK Investigational Site Bangkok, Thailand, 10400 GSK Investigational Site Mae Sot, Thailand, 63110 GSK Investigational Site Tak, Thailand, 63170 Vietnam GSK Investigational Site Ho Chi Minh, Vietnam Collapse << |
NCT02491606 | Malaria | Phase 2 | Completed | - | - |
NCT02658435 | Malaria, Vivax | Phase 1 | Completed | - | United States, California ... more >> GSK Investigational Site Glendale, California, United States, 91206 United States, Kansas GSK Investigational Site Overland Park, Kansas, United States, 66211 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21225 Collapse << |
NCT02216123 | - | - | Completed | - | - |
NCT02563496 | Malaria, Vivax | Phase 2 | Recruiting | November 30, 2019 | Colombia ... more >> GSK Investigational Site Recruiting Monteria, Colombia Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Thailand GSK Investigational Site Not yet recruiting Tak, Thailand, 63110 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Vietnam GSK Investigational Site Recruiting Hanoi, Vietnam, 100000 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Ho Chi Minh City, Vietnam, 700000 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Ho Chi Minh, Vietnam Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Collapse << |
NCT00871156 | Malaria | Phase 1 | Completed | - | United States, New York ... more >> GSK Investigational Site Buffalo, New York, United States, 14202 Collapse << |
NCT01290601 | Malaria Plasm... more >>odium Vivax Collapse << | Phase 2 | Terminated(Failure to meet pre... more >>-specified endpoint for the day 28 cure rate) Collapse << | - | Thailand ... more >> Bangkok Hospital for Tropical Diseases/Mahidol University Bangkok, Thailand, 10400 Collapse << |
NCT02488902 | Malaria | Phase 2 | Completed | - | - |
NCT02488980 | - | - | Completed | - | - |
NCT01928914 | Malaria, Vivax | Phase 1 | Completed | - | United States, California ... more >> GSK Investigational Site Culver City, California, United States, 90232 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21225 Collapse << |
NCT03320174 | Healthy Volunteers | Phase 2 | Recruiting | October 2020 | Australia, Western Australia ... more >> Linear Clinical Research Recruiting Nedlands, Western Australia, Australia, 6009 Contact: Shashi Aggarwal, PhD 1300 546 327 enquiries@linear.org.au Principal Investigator: Fred Chen, PhD, FRANZCO Collapse << |
NCT01290601 | - | - | Terminated(Failure to meet pre... more >>-specified endpoint for the day 28 cure rate) Collapse << | - | - |
NCT02488980 | Falciparum Parasitaemia | Phase 2 | Completed | - | - |
NCT02751294 | Malaria, Vivax | Phase 1 | Completed | - | United States, Maryland ... more >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网